| Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS TM Miller, ME Cudkowicz, A Genge, PJ Shaw, G Sobue, RC Bucelli, ... New England Journal of Medicine 387 (12), 1099-1110, 2022 | 311 | 2022 |
| Quantitative podocyte parameters predict human native kidney and allograft half-lives AS Naik, F Afshinnia, D Cibrik, JB Hodgin, F Wu, M Zhang, M Kikuchi, ... JCI insight 1 (7), 2016 | 29 | 2016 |
| Patient‐reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after SSRI … WW IsHak, J Mirocha, S Christensen, F Wu, R Kwock, J Behjat, S Pi, ... Depression and anxiety 31 (8), 707-716, 2014 | 27 | 2014 |
| Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS A Chan, J Rose, E Alvarez, A Bar-Or, H Butzkueven, RJ Fox, R Gold, ... Neurology: Clinical Practice 10 (6), 510-519, 2020 | 20 | 2020 |
| A pairwise likelihood augmented Cox estimator for left‐truncated data F Wu, S Kim, J Qin, R Saran, Y Li Biometrics 74 (1), 100-108, 2018 | 13 | 2018 |
| Real-world efficacy of delayed-release dimethyl fumarate in early multiple sclerosis: interim results from ESTEEM K Giles, K Balashov, CC Jones, R Macdonell, C Miller, J Windsheimer, ... MULTIPLE SCLEROSIS JOURNAL 24, 289-290, 2018 | 5 | 2018 |
| Efficacy of delayed-release dimethyl fumarate in newly diagnosed and other early MS patients, and patients switching from interferon or glatiramer acetate, in routine medical … K Giles, J Hanna, F Wu, C Taylor, K Balashov, R Macdonell, ... MULTIPLE SCLEROSIS JOURNAL 23, 612-613, 2017 | 4 | 2017 |
| Efficacy outcomes for diroximel fumarate compared with dimethyl fumarate: a propensity score matched analysis of EVOLVE-MS-1 and DEFINE/CONFIRM F Wu, R Gold, MS Freedman, C Ford, R Naismith, R Leigh-Pemberton, ... EUROPEAN JOURNAL OF NEUROLOGY 26, 680-681, 2019 | 3 | 2019 |
| Examining the impact of patient-reported hope for improvement and patient satisfaction with clinician/treatment on the outcome of major depressive disorder treatment WW IsHak, J Vilhauer, R Kwock, F Wu, S Gohar, K Collison, SN Thomas, ... International neuropsychiatric disease journal 7 (2), 2016 | 3 | 2016 |
| Real-world efficacy of delayed-release dimethyl fumarate in early multiple sclerosis: interim results from ESTEEM (P3. 2-081) K Giles, K Balashov, CC Jones, R Macdonell, C Miller, J Windsheimer, ... Neurology 92 (15_supplement), P3. 2-081, 2019 | 2 | 2019 |
| Delayed-release Dimethyl Fumarate Demonstrated No Difference in Clinical Outcomes Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the … J Sloane, JT Phillips, J Calkwood, A Van der Walt, J Min, F Wu, C Taylor Neurology 90 (15 Supplement), 2018 | 2 | 2018 |
| Comparative effectiveness analysis of Medicare dialysis facility survey processes S Kim, F Wu, C Dahlerus, D Chyn, Y Li, JM Messana Plos one 14 (4), e0216038, 2019 | 1 | 2019 |
| Among Real-world Multiple Sclerosis Patients That Experience Delayed-release Dimethyl Fumarate-associated Lymphopenia, Meaningful Lymphocyte Reconstitution Occurs Approximately … J Rose, E Alvarez, D Okuda, M Gudesblatt, E Riser, T Spelman, S Fam, ... Neurology 92 (15 Supplement), 2019 | | 2019 |
| Among real-world multiple sclerosis patients that experience delayed-release dimethyl fumarate-associated lymphopenia, meaningful lymphocyte reconstitution occurs within 3 … J Rose, E Alvarez, D Okuda, M Gudesblatt, E Riser, T Spelman, ... MULTIPLE SCLEROSIS JOURNAL 24, 678-679, 2018 | | 2018 |
| Real-world Effectiveness of Delayed-release Dimethyl Fumarate in Relapsing-remitting Multiple Sclerosis Patients Who Are Treatment-naïve or Treated With Only One Prior Therapy … J Calkwood, S Cohan, A Chan, E Lathi, A Van Der Walt, F Wu, J Min, ... Neurology 90 (15 Supplement), 2018 | | 2018 |
| Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed and Other Early Multiple Sclerosis Patients, and Patients Switching from Interferon or Glatiramer Acetate, in … K Giles, J Hanna, F Wu, C Taylor, K Balashov, R Macdonell, ... Neurology 90 (15 Supplement), 2018 | | 2018 |
| Analysis of Complex Survival and Longitudinal Data in Observational Study F Wu | | 2017 |
| Package ‘plac’ F Wu | | 2016 |
